Mechanism of mesenchymal stem cells in treating diabetic kidney disease.

Stem Cell Res Ther · 2025 · PMC12606926 · PMID 41220025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Notably, there may be significant differences between MSC-mediated Nrf2 activation and pharmacological activation using bardoxolone methyl.

also in 8,502 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.